久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Biogen Licenses CEVEC AAV Mfg. Technology contractpharma
    January 11, 2021
    Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.
  • CEVEC, Roche Ink ELEVECTA Technology License Agreement contractpharma
    November 12, 2020
    ?CEVEC Pharmaceuticals GmbH (CEVEC) signed an option and license agreement with Roche for the use of its newly launched ELEVECTA Technology for large scale manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service